SCHEMBL1899962

SCHEMBL1899962

CC(C)Nc1ccccc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.54
MEN1 O00255 4/20 0.54
FABP4 P15090 3/20 0.52
ALDH1A1 P00352 3/20 0.50
AKR1C3 P42330 3/20 0.50
AKR1B10 O60218 2/20 0.50
LMNA P02545 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
AKR1B1 P15121 2/20 0.50
PTGS2 P35354 2/20 0.50
AKR1C2 P52895 2/20 0.50
AKR1C1 Q04828 2/20 0.50
HIF1A Q16665 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
TRPA1 O75762 1/20 0.50
ABCB11 O95342 1/20 0.50
DHFR P00374 1/20 0.50
MPO P05164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25465849 0.89 KMT2A (0.51) KMT2AMEN1FABP4ALDH1A1AKR1C3
SCHEMBL25465846 0.89 KMT2A (0.51) KMT2AMEN1FABP4ALDH1A1AKR1C3
SCHEMBL19750094 0.86 KMT2A (0.53) KMT2AMEN1FABP4ALDH1A1AKR1C3
SCHEMBL29272447 0.85 KMT2A (0.49) KMT2AMEN1FABP4ALDH1A1AKR1C3
SCHEMBL5512525 0.85 KMT2A (0.51) KMT2AMEN1FABP4ALDH1A1AKR1C3
SCHEMBL31552440 0.84 AKR1C3 (0.46) KMT2AMEN1ALDH1A1AKR1C3AKR1B10
SCHEMBL12411070 0.84 AKR1C3 (0.46) KMT2AMEN1ALDH1A1AKR1C3AKR1B10
SCHEMBL1901606 0.83 CLCN2 (0.53) KMT2AMEN1FABP4ALDH1A1AKR1C3
SCHEMBL4591111 0.83 KDM4C (0.68) KMT2AMEN1FABP4ALDH1A1AKR1C3
SCHEMBL29590040 0.83 KDM4C (0.68) KMT2AMEN1FABP4ALDH1A1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365596-B2 Method for preparing quaternary phosphonium salts MICROVAST POWER SYSTEMS CO., LTD. (CN) 2016-06-14 US claimed
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS MICROVAST POWER SYSTEMS CO., LTD. (CN) 2015-06-18 US claimed
EP-3416176-B1 ELECTROLYTE SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING SAID ELECTROLYTE SOLUTION SANYO CHEMICAL IND LTD (JP) 2026-01-07 EP disclosed
CN-114674946-B Method for measuring four main components in N-isopropyl-anthranilamide synthesis reaction liquid 青岛科技大学 2024-05-14 CN disclosed
WO-2024090362-A1 CHARGE-TRANSPORTING COMPOSITION 日産化学株式会社 2024-05-02 WO disclosed
EP-4225739-A1 PREPARATION OF BENZIMIDAZOLONE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS Merck Sharp & Dohme LLC (US) 2023-08-16 EP disclosed
WO-2023081759-A1 BIFUNCTIONAL PI3K-ALPHA INHIBITORS AND USES THEREOF RELAY THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
EP-3480835-B1 ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR SANYO CHEMICAL IND LTD (JP) 2022-12-21 EP disclosed
US-11527365-B2 Electrolytic solution for electrolytic capacitor, and electrolytic capacitor SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2022-12-13 US disclosed
US-11424078-B2 Electrolytic solution for electrolytic capacitor, and electrolytic capacitor SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2022-08-23 US disclosed
CN-111247611-B Electrolytic solution for electrolytic capacitor and electrolytic capacitor 三洋化成工业株式会社 2022-07-05 CN disclosed
EP-0246825-B1 QUATERNARY SALT SOLUTION ELECTROLYTE FOR ELECTROLYTIC CAPACITORS MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1991-02-27 EP disclosed
EP-0381936-A1 An electrolyte for use in electrolytic capacitors MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1990-08-16 EP disclosed
US-4892944-A Process for producing quaternary salts MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1990-01-09 US disclosed
EP-0291074-A2 Process for producing quaternary salts MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1988-11-17 EP disclosed
US-4774011-A Electrolyte for aluminum electrolytic capacitor MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1988-09-27 US disclosed
US-4715976-A QUATERNARY AMMONIUM SALT OF CARBOXYLIC ACID IN APROTIC SOLVENT MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-12-29 US disclosed
EP-0246825-A2 Quaternary salt solution electrolyte for electrolytic capacitors MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-11-25 EP disclosed
EP-0227433-A2 Electrolyte solution of quaternary ammonium salt for electrolytic capacitor MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-07-01 EP disclosed
US-4670600-A Preparation of substituted amines SANDOZ PHARM. CORP. (US) 1987-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS PHPT1, PHOSPHO1, PTEN KMT2A 2330/4885MEN1 415/4885FABP4 4643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.